髄膜炎球菌病に対するワクチンの開発
Luis Jódar1, Ian M Feavers, David Salisbury
1Vaccine Development and Quality and Safety of Biologicals, World Health Organization, Geneva, Switzerland. jodar@who.org
Lancet (London, England)
|May 4, 2002
まとめ
ネイセリア meningitidis B群に対する新しいワクチンの開発は困難です. ゲノムデータは, Meningococal疾患に対する広範な保護を提供できる有望な保存された膜タンパク質を明らかにしています.
科学分野:
- 微生物学 微生物学とは
- ワクチン学 ワクチン学
- ゲノミクスゲノミクスとは
背景:
- ネイセリア meningitidisは,細菌性髄膜炎と敗血症を引き起こす.
- 既存のワクチンは特定の血清群をターゲットにしていますが,B群は依然として課題です.
- B群の従来型のワクチンは,抗原多様性と自己抗体誘導により,ほとんど成功していません.
研究 の 目的:
- Neisseria meningitidis group B.に対する新しいワクチン候補を探求する.
- ブロードスペクトル保護のための保存された抗原を特定する.
- 現在のワクチン開発戦略の限界を克服するために.
主な方法:
- 新しい抗原を特定するためのゲノムシーケンシング分析.
- ワクチン候補として新しい膜タンパク質の評価.
- ネズミのモデルにおける血清細菌殺菌抗体を含む免疫応答の評価.
主要な成果:
- ゲノム解析により,多数の新しい膜タンパク質が特定されました.
- これらの保存された抗原は,マウスの血清細菌殺菌抗体を誘発する.
- 新しいワクチン候補は,グループBの菌株に対する広範な保護の約束を示しています.
結論:
- 保存された膜タンパク質は,Neisseria meningitidis B群のワクチンの広範な保護性のための有望な標的を表しています.
- ゲノムに関する洞察は,困難な細菌病原体に対する効果的なワクチンの開発に不可欠です.
- 全世界の全髄膜炎球菌疾患を制御する見通しが改善されています.
関連する概念動画
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Bacterial Meningitis
Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...


